Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time

Rhea-AI Summary

DexCom announces an update regarding its first quarter 2022 earnings call, rescheduling it to start at 5:30 p.m. ET due to technical difficulties with the conference call provider. The link for the webcast will be available on the DexCom investor relations website and will be archived for future reference. Investors can listen to the call by dialing the provided numbers and using the confirmation number.

DexCom continues to focus on empowering diabetes management through innovative continuous glucose monitoring (CGM) systems, emphasizing its leadership in diabetes care technology.

Positive

• Continued focus on innovative continuous glucose monitoring (CGM) systems.
• Maintained leadership in diabetes care technology.

Negative

• Technical difficulties affecting the earnings call could signal operational challenges.

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. has updated its first quarter 2022 earnings call due to technical difficulties with the conference call provider. The conference call will now start at 5:30 p.m. (Eastern Time). The link to the webcast will be available on the DexCom, Inc. investor relations website at investors.dexcom.com and will be archived there for future reference.

To listen to the conference call, please dial (866) 374-5140 (US/Canada) or (404) 400-0571 (International) and use the confirmation number "41691074#" approximately five minutes prior to the start time.

About DexCom, Inc.

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, and with operations across Europe, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. For more information about Dexcom CGM, visit www.dexcom.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220428006330/en/

Media Contact

James McIntosh

619-884-2118

james.mcintosh@dexcom.com

Investor Contact

Sean Christensen

858-203-6657

sean.christensen@dexcom.com

Source: DexCom, Inc.

FAQ

What time is the DexCom Q1 2022 earnings call?

The DexCom Q1 2022 earnings call is rescheduled to start at 5:30 p.m. ET.

How can I listen to the DexCom earnings call?

You can listen to the DexCom earnings call by dialing (866) 374-5140 (US/Canada) or (404) 400-0571 (International) using confirmation number '41691074#'.

Where can I find the DexCom earnings call webcast?

The webcast link for the DexCom earnings call will be available on the DexCom investor relations website.

What is the stock symbol for DexCom?

The stock symbol for DexCom is DXCM.

What issues did DexCom face with the earnings call?

DexCom faced technical difficulties with the conference call provider, necessitating a rescheduling.